Expect them to be disappointing. That's what Saxo's Peter Garnry predicts ahead of...

Some big life assurance companies could soon prove to be troublesome for investors; that's...

Serge Berger suggests buying Biogen, a biotech firm which has reported sales of its Multiple...

What next in the drama surrounding the proposed merger of pharmaceutical giants Pfizer and...

You can no longer just be "long" US or European equities; you've now got to be more specific and...

A 'grexit' from the Euro seems possible, if not yet inevitable. The resulting sharp draw-down on...

The second qurter earnings season delivered positive earnings suprises in the majority of cases,...